Product Image

Ginkgo Biloba 60 mg

NOW
4.8
★ ★ ★ ★ ★
(3877 ratings)
Ginkgo
Product Image
Score74
A maintenance-level ginkgo extract paired with substantial leaf powder. It offers broad herb material but only partial potency transparency.
How scoring works
Quantity:120 Capsule(s) • (120 servings)
Goals:
Cognitive Support
Brain Health
Productivity Boost
Mental Focus

Score 74

A maintenance-level ginkgo extract paired with substantial leaf powder. It offers broad herb material but only partial potency transparency.
How scoring works
$11.60($0.09 per serving)
Daily Vita
$ 11.60
iHerb
$ 12.23
Amazon
$ 11.60
Vitacost
$ 12.03
Pure Formulas
$ 11.89
Report prices

Analysis

The capsule supplies 60 mg of extract plus 200 mg of ginkgo powder. Both main marker classes are named for the extract, though their percentages and a purity limit are absent.

The product may support cerebral circulation and selected cognitive functions at a maintenance level. Whole leaf adds botanical mass without providing the predictability of more standardized extract.

The capsule fits users who prefer a full-spectrum herb-plus-extract approach. People seeking a full clinical extract amount or direct vision nutrients may find it too limited.

Who is it for
  • Adults who prefer extract plus whole herb
  • People seeking mild cognitive maintenance
  • Users interested in circulation support
Best for
  • Daily low-intensity ginkgo use
  • Full-spectrum botanical routines
  • Adding ginkgo to a broader plan

Pros

  • Combines extract and leaf powder
  • Names both main marker classes
  • Provides a substantial total herb amount

Cons

  • Extract amount is modest
  • Marker percentages are not stated
  • Leaf powder does not replace standardization

Warnings

  • Ginkgo may increase bleeding risk with anticoagulants or antiplatelet medicines.
  • Use around surgery should be coordinated with the surgical team.
  • Headache, dizziness, or digestive discomfort may occur.

Nutrient quality

70 High impact

The key ginkgo marker groups are named, but their percentages and a purity limit are not fully disclosed. The formula supplies a maintenance-level extract amount, with no obvious overdosing.

.

Ingredient transparency

79 High impact

The main active amounts are clearly listed, and no proprietary blend hides them. Intake directions, non-active ingredients, and some extract-quality details are absent from the supplied data.

.

Customer satisfaction

70 High impact

The supplied average is very strong and the response volume is substantial. No detailed feedback is provided to assess recurring complaints or fit with the intended purpose.

.

Value for money

74 High impact

The serving cost is appealing, but incomplete extract verification limits confidence in value. A fully standardized extract would provide a more dependable comparison.

.
Report analysis

Goals

Cognitive Support
Impact
High effect
B Goal FitB+ Strength of SupportD CoverageB- Formula Quality

Ginkgo may support cerebral blood flow and selected aspects of memory, giving it a direct cognitive mechanism. The 60 mg extract amount is disclosed with flavonglycoside and terpene-lactone markers, alongside additional unstandardized leaf powder.

Evidence is mixed for cognitive enhancement in healthy adults and is more relevant to age-related decline or circulation-related needs. Ginkgo can increase bleeding risk with anticoagulant or antiplatelet medicines and around surgery.

Study evidence
Ginkgo Supportive 87 studies
Brain Health
Impact
High effect
B+ Goal FitC Strength of SupportD CoverageA- Formula Quality

Ginkgo directly targets cerebral circulation and has relevant human evidence for cognitive support. The extract amount is better suited to mild maintenance than a full clinical serving.

Both ginkgo marker groups are named, but the extract amount is modest and percentages are missing. Ginkgo may raise bleeding risk with anticoagulant or antiplatelet drugs, so concurrent use needs specific medical review.

Study evidence
Ginkgo Supportive 90 studies
Productivity Boost
Impact
Moderate effect
C Goal FitD+ Strength of SupportD- CoverageB+ Formula Quality

Ginkgo extract may support memory and cerebral circulation, but the extract amount is suited to mild use rather than a full clinical serving. Added ginkgo powder does not replace clear active-marker standardization.

The label names both main marker groups without stating their percentages or a ginkgolic-acid limit. Ginkgo may increase bleeding risk with anticoagulants or antiplatelet medicines.

Study evidence
Ginkgo Supportive 20 studies
Ginkgo Supportive 12 studies
Mental Focus
Impact
Moderate effect
C+ Goal FitD+ Strength of SupportD CoverageB- Formula Quality

Ginkgo may support focus through cerebral circulation and related cognitive mechanisms. Human evidence is mixed and depends heavily on using a well-standardized extract.

The 60 mg extract supports maintenance use, while added leaf powder does not substitute for standardized extract. Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 28 studies

Ingredients

IngredientAmount per serving
Ginkgo extract (Ginkgoflavonglycosides, Terpene Lactones)
60 mg
Ginkgo powder
200 mg
Gluten Free Men 18–50 Vegan Kosher Women Vegetarian
Report overview
F Active Ingredient Quality & BioavailabilityB+ Dose, Safety & Label TransparencyA+ Value

The extract amount is suited to mild maintenance rather than a full clinical serving. Both active-marker groups are named without percentages, and no ginkgolic-acid purity guarantee is given. Ginkgo may raise bleeding risk with anticoagulants or antiplatelet drugs, so concurrent use requires specific medical review.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledBrain Health forGinkgo
  2. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledBrain Health Cognitive Support forGinkgo
  3. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledBrain Health Productivity Boost forGinkgo
  4. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsBrain Health Productivity Boost forGinkgo
  5. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsBrain Health forGinkgo
  6. Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
    Tian X; Xu Q; Xia X; Zhang Y; Meng X; Wang A · Journal of neurology · 2024
    Randomized trial3,163 participantsCognitive Support forGinkgo
  7. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF · JAMA · 1997
    Randomized trial309 participantsCognitive Support Productivity Boost forGinkgo
  8. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
    Bachinskaya N; Hoerr R; Ihl R · Neuropsychiatric disease and treatment · 2011
    Randomized trial410 participantsCognitive Support forGinkgo
  9. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
    Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O; GOTADAY Study Group · International journal of geriatric psychiatry · 2013
    Randomized trial410 participantsCognitive Support forGinkgo
  10. Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
    Hort J; Duning T; Hoerr R · Neuropsychiatric disease and treatment · 2023
    Systematic review946 participants9 studies pooledMental Focus forGinkgo
  11. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Randomized trial216 participantsMental Focus forGinkgo
  12. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Pharmacopsychiatry · 1996
    Randomized trial216 participantsMental Focus forGinkgo
  13. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
    Li S; Zhang X; Fang Q; Zhou J; Zhang M; Wang H; Chen Y; Xu B; Wu Y; Qian L; Xu Y · Stroke and vascular neurology · 2021
    Randomized trial348 participantsMental Focus forGinkgo
  14. Ginkgo biloba in the Aging Process: A Narrative Review.
    Barbalho SM; Direito R; Laurindo LF; Marton LT; Guiguer EL; Goulart RA; Tofano RJ; Carvalho ACA; Flato UAP; Capelluppi Tofano VA; Detregiachi CRP; Bueno PCS; Girio RSJ; Araújo AC · Antioxidants (Basel, Switzerland) · 2024
    Narrative review14 studies pooledMental Focus forGinkgo
  15. [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
    Kasper S; Schubert H · Fortschritte der Neurologie-Psychiatrie · 2009
    Meta-analysis10 studies pooledProductivity Boost forGinkgo
  16. Dietary Flavonoids and Human Cognition: A Meta-Analysis.
    Cheng N; Bell L; Lamport DJ; Williams CM · Molecular nutrition & food research · 2022
    Meta-analysis5,519 participants80 studies pooledProductivity Boost forGinkgo
  17. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba.
    Elsabagh S; Hartley DE; File SE · Journal of psychopharmacology (Oxford, England) · 2005
    Randomized trial87 participantsProductivity Boost forGinkgo
  18. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial.
    Gavrilova SI; Preuss UW; Wong JW; Hoerr R; Kaschel R; Bachinskaya N; GIMCIPlus Study Group · International journal of geriatric psychiatry · 2015
    Randomized trial160 participantsProductivity Boost forGinkgo
  19. Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers.
    Kennedy DO; Jackson PA; Haskell CF; Scholey AB · Human psychopharmacology · 2008
    Randomized trial78 participantsProductivity Boost forGinkgo